Biotricity, Inc.BTCYNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +21.73% | +16.50% | +21.00% | +18.95% | +10.19% |
| Gross Profit Growth | +27.49% | +31.06% | +31.89% | +29.37% | +17.64% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +169.87% | +140.46% | +85.50% | +16.85% | +13.86% |
| Weighted Average Shares Diluted Growth | +169.87% | +140.46% | +85.50% | +16.85% | +13.86% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +76.77% | +50.61% | +22.59% | +1.22% | -43.26% |
| Inventory Growth | -23.37% | -17.24% | -6.79% | +24.14% | +25.77% |
| Asset Growth | +9.14% | -5.08% | +11.37% | +19.48% | -5.03% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +12.70% | +9.26% | +15.16% | -41.46% | +6.41% |
| R&D Expense Growth | +21.69% | -19.16% | +35.47% | +16.37% | +13.13% |
| SG&A Expenses Growth | -20.52% | -29.24% | -27.90% | +2.49% | -8.18% |